Skip to main content
Premium Trial:

Request an Annual Quote

IDbyDNA: Neil Gunn, Guochun Liao

Neil Gunn has been appointed as CEO of pathogen detection firm IDbyDNA, succeeding Guochun Liao, the firm's cofounder, in this role. Gunn joins the company from Roche Diagnostics, where he was president and head of the sequencing business unit. Previously, he led commercial operations, global marketing, and the Americas business at Chiron, where he helped introduce HIV and HCV molecular blood screening tests.

Liao will become IDbyDNA's chief innovation officer and serve as the company's president and board chairman.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.